Morrell Martha, CMO, reported a transaction classified as withholding at NeuroPace Inc involving 1413.000000 shares for an estimated $16857.09. Reported holdings after the transaction were 47340.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
Form 4 relationship flags and nearby filing context
CHIEF MEDICAL OFFICER
25% of the shares subject to the option vest on July 1, 2015; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
25% of the shares subject to the option vest on July 1, 2013; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
25% of the shares subject to the option vest on July 1, 2012; 1/48th of the shares subject to the option vest in 36 equal monthly installments thereafter.
1/48th of the shares subject to the option vest in equal monthly installments commencing February 1, 2017.
0 other filings
0 recent txs